Search - tctmd.com

Displaying 661 - 680 of 818

Sort: Relevancy | Date

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Industry News

Cardiostim Symposium Demonstrates BIOTRONIK Home Monitoring® Advantages for Effective Management of Heart Failure Patients

June 19, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Caitlin E. Cox

May 22, 2014

News Industry News

St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

May 07, 2014

News Industry News

Cardiotek Announces U.S. Commercialization of the EP-Tracer System

May 07, 2014

News Industry News

St. Jude Medical Shows Commitment to Cardiac Advancements With Comprehensive Clinical Evidence Program During Heart Rhythm 2014

May 05, 2014

News Industry News

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

May 05, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

Presentation Fellows 2014

Septal Ablation for HOCM

Presenter: Srihari Naidu

April 14, 2014

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

News Industry News

Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the United States to Use FDA-Approved ThermoCool® SmartTouch® Catheter

March 21, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

Percutaneous Chemical Ablation of Cardiac Nerves Shows Promise in Treating A-fib

L.A. McKeown

February 26, 2014

News Daily News

La Ablación Química Percutánea de Nervios Cardíacos resulta Prometedora en el Tratamiento de la FA

L.A. McKeown

February 26, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

Advertisement

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Cardiostim Symposium Demonstrates BIOTRONIK Home Monitoring® Advantages for Effective Management of Heart Failure Patients

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

Cardiotek Announces U.S. Commercialization of the EP-Tracer System

St. Jude Medical Shows Commitment to Cardiac Advancements With Comprehensive Clinical Evidence Program During Heart Rhythm 2014

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

Renal Denervation Shows Promise in Patients Refractory to Stenting

Septal Ablation for HOCM

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the United States to Use FDA-Approved ThermoCool® SmartTouch® Catheter

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Percutaneous Chemical Ablation of Cardiac Nerves Shows Promise in Treating A-fib

La Ablación Química Percutánea de Nervios Cardíacos resulta Prometedora en el Tratamiento de la FA

Survival After Septal Ablation for HOCM Similar to General Population

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content